NRG Therapeutics selects Domainex to be its integrated drug discovery partner for its Biomedical Cat
Cambridge and Stevenage, United Kingdom, 30th June 2022 / Sciad Newswire / NRG Therapeutics Ltd., an innovative neuroscience company targeting mitochondrial dysfunction, and Domainex Ltd., today announce a collaboration focused on developing novel small molecule disease-modifying medicines for the treatment of Parki...
United Kingdom Deborah Cockerill Jasmin Shearan Neil Miller Linkedin Biologybiotechnologychemistrylife Sciencepress Sue Charles Sciad Communications
Source: pharmiweb.com